Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.

Kuramochi H, Hayashi K, Nakajima G, Kamikozuru H, Yamamoto M, Danenberg KD, Danenberg PV.

Cancer Chemother Pharmacol. 2010 Apr;65(5):825-31. doi: 10.1007/s00280-009-1087-5. Epub 2009 Aug 22.

PMID:
19701635
2.

Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compared with corresponding primary colorectal cancer.

Kuramochi H, Hayashi K, Uchida K, Miyakura S, Shimizu D, Vallböhmer D, Park S, Danenberg KD, Takasaki K, Danenberg PV.

Clin Cancer Res. 2006 Jan 1;12(1):29-33.

3.

Messenger RNA expression of COX-2 and angiogenic factors in primary colorectal cancer and corresponding liver metastasis.

Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Iida S, Lenz HJ, Danenberg KD, Danenberg PV.

Int J Oncol. 2009 Apr;34(4):1147-53.

PMID:
19287974
4.

Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases.

Maurer CA, Graber HU, Friess H, Beyermann B, Willi D, Netzer P, Zimmermann A, Büchler MW.

Surgery. 1999 Nov;126(5):869-80.

PMID:
10568187
5.

Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis.

Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Iida S, Azuma M, Mori R, Omori A, Lenz HJ, Danenberg KD, Danenberg PV.

Int J Oncol. 2008 Dec;33(6):1257-62.

PMID:
19020759
6.

EGFR, HER-2 and COX-2 levels in colorectal cancer.

Antonacopoulou AG, Tsamandas AC, Petsas T, Liava A, Scopa CD, Papavassiliou AG, Kalofonos HP.

Histopathology. 2008 Dec;53(6):698-706.

PMID:
19102009
7.

Redifferentiation and ZO-1 reexpression in liver-metastasized colorectal cancer: possible association with epidermal growth factor receptor-induced tyrosine phosphorylation of ZO-1.

Kaihara T, Kawamata H, Imura J, Fujii S, Kitajima K, Omotehara F, Maeda N, Nakamura T, Fujimori T.

Cancer Sci. 2003 Feb;94(2):166-72.

8.

Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.

De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De Vries EG.

Hepatology. 1998 Oct;28(4):971-9.

PMID:
9755233
9.

Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis.

Kobayashi H, Sugihara K, Uetake H, Higuchi T, Yasuno M, Enomoto M, Kuramochi H, Lenz HJ, Danenberg KD, Danenberg PV.

Ann Surg Oncol. 2008 Apr;15(4):1232-8. doi: 10.1245/s10434-008-9811-7. Epub 2008 Feb 1.

PMID:
18239970
10.

Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.

Scartozzi M, Bearzi I, Berardi R, Mandolesi A, Fabris G, Cascinu S.

J Clin Oncol. 2004 Dec 1;22(23):4772-8. Erratum in: J Clin Oncol. 2005 Jan 1;23(1):248.

PMID:
15570078
11.

EGFR expression variance in paired colorectal cancer primary and metastatic tumors.

Yarom N, Marginean C, Moyana T, Gorn-Hondermann I, Birnboim HC, Marginean H, Auer RC, Vickers M, Asmis TR, Maroun J, Jonker D.

Cancer Biol Ther. 2010 Sep 1;10(5):416-21. Epub 2010 Sep 8.

PMID:
20595818
12.

Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.

Sato T, Oshima T, Yoshihara K, Yamamoto N, Yamada R, Nagano Y, Fujii S, Kunisaki C, Shiozawa M, Akaike M, Rino Y, Tanaka K, Masuda M, Imada T.

Oncol Rep. 2009 Jan;21(1):211-6.

PMID:
19082464
13.

Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis.

Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M, Sugihara K.

Cancer Chemother Pharmacol. 2004 May;53(5):391-6. Epub 2004 Jan 20.

PMID:
15060742
14.

Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.

Gentner B, Wein A, Croner RS, Zeittraeger I, Wirtz RM, Roedel F, Dimmler A, Dorlaque L, Hohenberger W, Hahn EG, Brueckl WM.

Anticancer Res. 2009 Jan;29(1):67-74.

15.

Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.

Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T.

Oncol Rep. 2006 Apr;15(4):875-82.

PMID:
16525674
16.

[Expression of thymidine phosphorylase in primary colorectal cancer and liver metastasis-relationship between mRNA levels in cancer cells and protein levels in cancerous tissue].

Ishibashi K, Sobajima J, Ishiguro T, Okada N, Miyazaki T, Yokoyama M, Ishida H.

Gan To Kagaku Ryoho. 2009 Mar;36(3):425-9. Japanese.

PMID:
19295266
17.

Clinical significance of BMP7 in human colorectal cancer.

Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.

Ann Surg Oncol. 2008 May;15(5):1530-7. doi: 10.1245/s10434-007-9746-4. Epub 2008 Feb 8.

PMID:
18259822
18.
19.

High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.

Deng Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E.

Am J Clin Oncol. 2009 Jun;32(3):245-52. doi: 10.1097/COC.0b013e3181891326.

PMID:
19451802
20.

Molecular factors of 5-fluorouracil metabolism in colorectal cancer: analysis of primary tumor and lymph node metastasis.

Vallböhmer D, Kuramochi H, Shimizu D, Danenberg KD, Lindebjerg J, Nielsen JN, Jakobsen A, Danenberg PV.

Int J Oncol. 2006 Feb;28(2):527-33.

PMID:
16391809

Supplemental Content

Support Center